<--- Back to Details
First PageDocument Content
Alkylating antineoplastic agents / Antiemetics / Chemotherapy-induced nausea and vomiting / Prodrugs / Cyclophosphamide / 5-HT3 antagonist / Chemotherapy / Cisplatin / Medicine / Chemistry / Oncology
Date: 2014-05-30 12:01:38
Alkylating antineoplastic agents
Antiemetics
Chemotherapy-induced nausea and vomiting
Prodrugs
Cyclophosphamide
5-HT3 antagonist
Chemotherapy
Cisplatin
Medicine
Chemistry
Oncology

P11444 - ASCO2014 MEC and HEC

Add to Reading List

Source URL: www.tesarobio.com

Download Document from Source Website

File Size: 303,15 KB

Share Document on Facebook

Similar Documents

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 1a4Ek - View Document

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 19OCx - View Document

Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella

Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella

DocID: 19AF1 - View Document

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 199Dl - View Document

P11444 - ASCO2014 MEC and HEC

P11444 - ASCO2014 MEC and HEC

DocID: 1987o - View Document